Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V. is dated March 28, 2019. The registrant is a foreign private issuer based in Jena, Germany, and files annual reports under Form 20-F. The filing serves to distribute a press release dated March 28, 2019, as indicated in the exhibit index.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document consists solely of the cover page and exhibit index for a press release, without embedded financial tables or narrative data.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods. No comparative financial data or operational updates are included in the provided content.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. The content is limited to the formal submission of a press release (Exhibit 99.1) without the release text itself.
Investor Verification Checklist
- Verify the content of the referenced press release (Exhibit 99.1) to understand the specific announcement made on March 28, 2019.
- Review the company's most recent Form 20-F or quarterly reports for actual financial metrics, as this Form 6-K does not contain them.
- Confirm if the press release addresses clinical trial results, partnership agreements, or capital raises, which are common triggers for such filings in biotechnology firms.